Cancer Science & Therapy

ISSN: 1948-5956

Open Access

Special Issue

Cancer history: A severe risk factor in Covid-19 patients
Cancer history: A severe risk factor in Covid-19 patients

Journal of Cancer Science & Therapy is pleased to announce Special issue on the topic “Cancer history: A severe risk factor in Covid-19 patients”.

With the available global data on spread of corona virus and mortality rate in Covid-19 patients, there has been an increased risk in expression of the symptoms and mortality in patients with cancer history or patients undergoing cancer treatment. The incidence of COVID-19 in patients with cancer would be more informative in assessing whether or not patients with cancer have an increased risk of COVID-19. Additionally, there are reports that patients with cancer were prone to severe events (admission to the intensive care unit requiring invasive ventilation, or death) from COVID-19. Evidence indicates that overwhelming inflammation and cytokine-associated lung injury could be important in instigating these severe events in patients with COVID-19.

In the process of making more information available about this topic on an open access platform, Journal of Cancer Science & Therapy would like to invite all the Researchers/Doctors/Medical Professionals/Institutions to submit Case-report,  research, review, short commentary, opinion, perspective or any kind of article related to the topic and it will be processed within the next 15 days and published in our May month special issue.

Submission Process 

  • Special issue articles can include both original unpublished research articles and review articles related to the specific theme
  • Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
  • All the articles in special issues should strictly adhere to journal style and formatting.
  • Each special issue can be created with 5-7 articles.
  • All accepted manuscripts can be submitted online https://www.scholarscentral.org/submissions/cancer-science-therapy.html or send as an e-mail attachment to the Editorial Office at [email protected] 
  • Submission should be accompanied by a cover letter with reference to the concerned special issue theme.

Please visit Instruction for authors page to know more about article formatting and guidelines: https://www.hilarispublisher.com/cancer-science-therapy/instructionsforauthors.html

Relevant Topics

Recommended Conferences

Cancer Meet 2020

San Francisco, USA


tempobet giriş

tempobet giriş


tipobet yeni giriş adresi tipobet e yeni giriş tipobet güncel giriş adresi imajbet giriş adresi

mobilbahis giriş

arrow_upward arrow_upward